HG-1440

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1440

Drug Alias NameCD55 modulator (Human Genome Sciences)CR modulator (Human Genome Sciences)TC modulator (Human Genome Sciences)decay accelerating factor for complement modulator (Human Genome Sciences)decay-accelerating factor 3 modulator (Human Genome Sciences) +[8]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionComplement decay-accelerating factor modulators

TargetsComplement decay-accelerating factor

Therapy Area/IndicationsImmune System DiseasesCardiovascular DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesCardiovascular DiseasesNeoplasms

Other Information

ATC CodeN/A